GB202214117D0 - Detecting cancer - Google Patents
Detecting cancerInfo
- Publication number
- GB202214117D0 GB202214117D0 GBGB2214117.0A GB202214117A GB202214117D0 GB 202214117 D0 GB202214117 D0 GB 202214117D0 GB 202214117 A GB202214117 A GB 202214117A GB 202214117 D0 GB202214117 D0 GB 202214117D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- detecting cancer
- cancer
- detecting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
- G01N33/57488—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70567—Nuclear receptors, e.g. retinoic acid receptor [RAR], RXR, nuclear orphan receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2214117.0A GB202214117D0 (en) | 2022-09-27 | 2022-09-27 | Detecting cancer |
PCT/EP2023/076521 WO2024068614A1 (en) | 2022-09-27 | 2023-09-26 | Detecting cancer |
PCT/EP2023/076511 WO2024068606A1 (en) | 2022-09-27 | 2023-09-26 | Detecting cancer |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2214117.0A GB202214117D0 (en) | 2022-09-27 | 2022-09-27 | Detecting cancer |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202214117D0 true GB202214117D0 (en) | 2022-11-09 |
Family
ID=83978606
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2214117.0A Pending GB202214117D0 (en) | 2022-09-27 | 2022-09-27 | Detecting cancer |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202214117D0 (en) |
-
2022
- 2022-09-27 GB GBGB2214117.0A patent/GB202214117D0/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB201808476D0 (en) | Biomarkers for colorectal cancer | |
EP3914733A4 (en) | Detecting endometrial cancer | |
GB201919219D0 (en) | Cancer biomarkers | |
IL299044A (en) | Advanced ransomware detection | |
EP4051811A4 (en) | Detecting ovarian cancer | |
GB201915469D0 (en) | Cancer detection methods | |
GB202103080D0 (en) | Cancer biomarkers | |
GB202214114D0 (en) | Detecting cancer | |
GB202214117D0 (en) | Detecting cancer | |
GB2595425B (en) | Prostate cancer biomarkers | |
GB201905861D0 (en) | Methods of detecting cancer | |
GB202311999D0 (en) | Methods for detecting cancer | |
GB201913957D0 (en) | Cancer | |
GB202019682D0 (en) | Biomarkers for detecting cancer | |
GB202305326D0 (en) | Colorectal cancer detection | |
GB202020493D0 (en) | Cancer biomarkers | |
GB202013476D0 (en) | Cancer biomarkers | |
GB202203260D0 (en) | Multi-cancer detection | |
GB202000739D0 (en) | Cancer | |
GB2596502B (en) | Crypto-jacking detection | |
GB202208312D0 (en) | Presence detection | |
EP3774876A4 (en) | Biomarker for detecting cancer | |
IL307858A (en) | Biomarkers for colorectal cancer | |
GB202205632D0 (en) | Detector | |
GB202314087D0 (en) | Biomarker for cancer |